{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:40:48Z","timestamp":1792683648706,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijid.2026.109099","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:05:48Z","timestamp":1788537948000},"page":"109099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Is a molecular rapid diagnostic test for rifampicin and isoniazid resistance in tuberculosis financially feasible? An economic evaluation in Indonesia"],"prefix":"10.1016","volume":"172","author":[{"given":"Ibrahim Nur Insan Putra","family":"Dharmawan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3095-2064","authenticated-orcid":false,"given":"Bilqis Iasha Rosma","family":"Sumroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8305-1250","authenticated-orcid":false,"given":"Salsabila","family":"Hulwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luthfiyah Zanida","family":"Putri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafira","family":"Husna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assica Permata Amalya","family":"Hakiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8447-892X","authenticated-orcid":false,"given":"Muhammad Prasetio","family":"Wardoyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eghar","family":"Anugrapaksi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budi","family":"Haryanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Fuady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlina","family":"Burhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.109099_bib0001","first-page":"1","author":"Global Tuberculosis Report","year":"2024"},{"key":"10.1016\/j.ijid.2026.109099_bib0002","doi-asserted-by":"crossref","first-page":"984","DOI":"10.4269\/ajtmh.22-0142","article-title":"Characteristics of drug-sensitive and drug-resistant tuberculosis cases among adults at Tuberculosis Referral Hospitals in Indonesia","volume":"107","author":"Burhan","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2026.109099_bib0003","unstructured":"World Health Organization. WHO Consolidated Guidelines on Tuberculosis. Module 3: Diagnosis Rapid Diagnostics for Tuberculosis Detection [Internet]. Third edition. Geneva; 2024 [cited 2026 Nov 13]. p. 1. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240107984."},{"key":"10.1016\/j.ijid.2026.109099_bib0004","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/17576180.2024.2349423","article-title":"Tuberculosis diagnosis versus GeneXpert\u00ae MTB\/RIF formats","volume":"16","author":"Khan","year":"2024","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ijid.2026.109099_bib0005","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1186\/s12879-024-10027-6","article-title":"Dynamic modelling of improved diagnostic testing for drug-resistant tuberculosis in high burden settings","volume":"24","author":"Getchell","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2026.109099_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/bmjph-2023-000276","article-title":"Cost-effectiveness of diagnostic tools and strategies for the screening and diagnosis of tuberculosis disease and infection: a scoping review","volume":"2","author":"Ockhuisen","year":"2024","journal-title":"BMJ Public Health"},{"key":"10.1016\/j.ijid.2026.109099_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290496","article-title":"Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing","volume":"18","author":"Malhotra","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2026.109099_bib0008","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment. Geneva, 2022."},{"key":"10.1016\/j.ijid.2026.109099_bib0009","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-susceptible tuberculosis treatment. Geneva, 2022."},{"key":"10.1016\/j.ijid.2026.109099_bib0010","unstructured":"Home, 2022. TB Indonesia [Internet], https:\/\/www.tbindonesia.or.id\/; (accessed 2025 Dec 22)."},{"key":"10.1016\/j.ijid.2026.109099_bib0011","unstructured":"Home, 2023. TB Indonesia [Internet], https:\/\/www.tbindonesia.or.id\/; (accessed 2025 Dec 22)."},{"key":"10.1016\/j.ijid.2026.109099_bib0012","unstructured":"Home, 2024. TB Indonesia [Internet], https:\/\/www.tbindonesia.or.id\/; (accessed 2025 Dec 22)."},{"key":"10.1016\/j.ijid.2026.109099_bib0013","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12879-023-08348-z","article-title":"Declining incidence rate of tuberculosis among close contacts in five years post-exposure: a systematic review and meta-analysis","volume":"23","author":"Du","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2026.109099_bib0014","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(16)30407-8","article-title":"Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis","volume":"17","author":"Gegia","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.109099_bib0015","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12879-015-1101-y","article-title":"Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia","volume":"15","author":"Lisdawati","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2026.109099_bib0016","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijtb.2023.03.019","article-title":"Detection of katG, inhA and ahpC gene mutation in clinical isolates of isoniazid-resistant Mycobacterium tuberculosis in Makassar City, South Sulawesi, Indonesia","volume":"71","author":"Junaedi","year":"2024","journal-title":"Indian J Tuberc"},{"key":"10.1016\/j.ijid.2026.109099_bib0017","series-title":"Tuberculosis control in Indonesia","year":"2022"},{"key":"10.1016\/j.ijid.2026.109099_bib0018","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5588\/ijtldopen.24.0524","article-title":"Treatment success rate and time to culture conversion under a prospective BPaL cohort study","volume":"2","author":"Burhan","year":"2025","journal-title":"IJTLD Open"},{"key":"10.1016\/j.ijid.2026.109099_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076189","article-title":"The impact of isoniazid resistance on the treatment outcomes of smear positive re-treatment tuberculosis patients in the State of Andhra Pradesh, India","volume":"8","author":"Deepa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2026.109099_bib0020","article-title":"Treatment outcomes among patients with isoniazid mono-resistant tuberculosis in Mumbai, India: a retrospective cohort study","volume":"37","author":"Khan","year":"2024","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.ijid.2026.109099_bib0021","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/S0140-6736(22)02078-5","article-title":"Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (Stream stage 2): an open-label, multicentre, randomised, non-inferiority trial","volume":"400","author":"Goodall","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2026.109099_bib0022","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jinf.2023.06.014","article-title":"Global treatment outcomes of extensively drug-resistant tuberculosis in adults: a systematic review and meta-analysis","volume":"87","author":"Pedersen","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2026.109099_bib0023","first-page":"230 p.","author":"Tuberkulosis Resistan PTP. Obat di Indonesia","year":"2020"},{"key":"10.1016\/j.ijid.2026.109099_bib0024","unstructured":"Reguler TP, Tahun E. RS persahabatan; 2025. Located at: Jakarta, Indonesia, 2025."},{"key":"10.1016\/j.ijid.2026.109099_bib0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.56338\/jphp.v6i1.6854","article-title":"Evaluation and study of the cost of illness of tuberculosis in Indonesia: a systematic review","volume":"6","author":"Nova","year":"2025","journal-title":"J Public Health Pharm"},{"key":"10.1016\/j.ijid.2026.109099_bib0026","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1183\/09031936.00193413","article-title":"Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review","volume":"43","author":"Tanimura","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2026.109099_bib0027","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/cid\/ciz932","article-title":"Multicenter study of the accuracy of the BD MAX multidrug-resistant tuberculosis assay for detection of Mycobacterium tuberculosis complex and mutations associated with resistance to rifampin and isoniazid","volume":"71","author":"Shah","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.109099_bib0028","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1128\/JCM.00571-11","article-title":"Evaluation of the Bactec MGIT 960 system in combination with the MGIT TBc identification test for detection of Mycobacterium tuberculosis complex in respiratory specimens","volume":"49","author":"Lu","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2026.109099_bib0029","doi-asserted-by":"crossref","first-page":"223","DOI":"10.24293\/ijcpml.v26i2.1425","article-title":"Profile of rapid molecular test of tuberculosis using Xpert MTB\/RIF","volume":"26","author":"Faraid","year":"2020","journal-title":"Indonesian J Clin Pathol Med Lab"},{"key":"10.1016\/j.ijid.2026.109099_bib0030","doi-asserted-by":"crossref","first-page":"00708","DOI":"10.1183\/23120541.00708-2020","article-title":"The role of chest radiography in the diagnosis of bacteriologically confirmed pulmonary tuberculosis in hospitalised Xpert MTB\/RIF-negative patients","volume":"7","author":"Kebede","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.ijid.2026.109099_bib0031","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jinf.2022.05.017","article-title":"Molecular detection of isoniazid monoresistance improves tuberculosis treatment: a retrospective cohort in France","volume":"85","author":"Bachir","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2026.109099_bib0032","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1183\/09031936.00065311","article-title":"The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis","volume":"39","author":"Oxlade","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2026.109099_bib0033","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40249-017-0382-3","article-title":"Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia\u2019s implementation of universal health coverage","volume":"7","author":"Fuady","year":"2018","journal-title":"Infect Dis Poverty"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226007344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226007344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:52:55Z","timestamp":1792680775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226007344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S1201971226007344"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109099","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is a molecular rapid diagnostic test for rifampicin and isoniazid resistance in tuberculosis financially feasible? An economic evaluation in Indonesia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"109099"}}